All In Biotech

Drug Trial Radar · NCT04671667

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 188 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

188

Planned (sponsor's estimate)

Start

Apr 27, 2021

Primary completion

Jun 30, 2029

Study completion Jun 30, 2029

Sponsor

Sponsor type
NIH
First posted
Dec 17, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.

Conditions

  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Oral Cavity Squamous Cell Carcinoma
  • Recurrent Oropharyngeal Squamous Cell Carcinoma

Interventions

  • CarboplatinDrug

    Given IV

  • CisplatinDrug

    Given IV

  • Computed TomographyProcedure

    Undergo CT

  • Intensity-Modulated Radiation TherapyRadiation

    Undergo IMRT

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • PembrolizumabBiological

    Given IV

  • Proton Beam Radiation TherapyRadiation

    Undergo PBRT

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall survival (OS)Time frame: From randomization to date of death from any cause, measured at 2 years
  2. Incidence of adverse eventsTime frame: Up to 5 years from date of registration

Locations

178 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama · Active not recruiting

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas · Recruiting

  • Kaiser Permanente-Anaheim

    Anaheim, California · Recruiting

  • Kaiser Permanente-Bellflower

    Bellflower, California · Recruiting

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Active not recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Active not recruiting

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California · Recruiting

  • Kaiser Permanente-Ontario

    Ontario, California · Recruiting

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California · Active not recruiting

  • Sutter Cancer Centers Radiation Oncology Services-Roseville

    Roseville, California · Active not recruiting

  • Sutter Roseville Medical Center

    Roseville, California · Active not recruiting

  • California Protons Cancer Therapy Center

    San Diego, California · Active not recruiting

  • Smilow Cancer Center/Yale-New Haven Hospital

    New Haven, Connecticut · Recruiting

  • Yale University

    New Haven, Connecticut · Recruiting

  • Smilow Cancer Hospital Care Center-Trumbull

    Trumbull, Connecticut · Recruiting

  • Smilow Cancer Hospital Care Center - Waterford

    Waterford, Connecticut · Recruiting

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia · Recruiting

  • UM Sylvester Comprehensive Cancer Center at Coral Gables

    Coral Gables, Florida · Recruiting

  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach

    Deerfield Beach, Florida · Recruiting

  • UF Health Cancer Institute - Gainesville

    Gainesville, Florida · Active not recruiting

  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida · Recruiting

  • UM Sylvester Comprehensive Cancer Center at Plantation

    Plantation, Florida · Recruiting

  • Moffitt Cancer Center-International Plaza

    Tampa, Florida · Recruiting

  • Moffitt Cancer Center - McKinley Campus

    Tampa, Florida · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Recruiting

  • Moffitt Cancer Center at Wesley Chapel

    Wesley Chapel, Florida · Recruiting

  • Emory Proton Therapy Center

    Atlanta, Georgia · Recruiting

  • Emory University Hospital Midtown

    Atlanta, Georgia · Recruiting

  • Emory University Hospital/Winship Cancer Institute

    Atlanta, Georgia · Suspended

  • Memorial Health University Medical Center

    Savannah, Georgia · Suspended

  • Northwestern University

    Chicago, Illinois · Recruiting

  • John H Stroger Jr Hospital of Cook County

    Chicago, Illinois · Recruiting

  • University of Illinois

    Chicago, Illinois · Recruiting

  • Carle at The Riverfront

    Danville, Illinois · Recruiting

  • Cancer Care Specialists of Illinois - Decatur

    Decatur, Illinois · Suspended

  • Decatur Memorial Hospital

    Decatur, Illinois · Recruiting

  • Northwestern Medicine Cancer Center Kishwaukee

    DeKalb, Illinois · Recruiting

  • Carle Physician Group-Effingham

    Effingham, Illinois · Recruiting

  • Crossroads Cancer Center

    Effingham, Illinois · Recruiting

  • Northwestern Medicine Cancer Center Delnor

    Geneva, Illinois · Recruiting

Showing 40 of 178 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.